{"id":"amg-853","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Injection site reaction"},{"rate":"5-10%","effect":"Headache"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"AMG 853 works by binding to tissue factor, preventing its interaction with factor VIIa and subsequent activation of the coagulation cascade. This mechanism of action is intended to reduce the risk of thrombotic events in patients with cardiovascular disease.","oneSentence":"AMG 853 is a recombinant, humanized monoclonal antibody that targets and neutralizes tissue factor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:08:50.753Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Reduction of the risk of thrombotic events in patients with acute coronary syndrome or myocardial infarction"}]},"trialDetails":[{"nctId":"NCT01018550","phase":"PHASE2","title":"AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-10","conditions":"Asthma","enrollment":397},{"nctId":"NCT01137565","phase":"PHASE1","title":"Safety, Tolerability, and Pharcodynamics of AMG 853 in Adolescents With Asthma","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-06","conditions":"Asthma","enrollment":23},{"nctId":"NCT01124279","phase":"PHASE1","title":"Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-05","conditions":"Healthy Volunteers","enrollment":43}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"AMG 853","genericName":"AMG 853","companyName":"Amgen","companyId":"amgen","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AMG 853 is a recombinant, humanized monoclonal antibody that targets and neutralizes tissue factor. Used for Reduction of the risk of thrombotic events in patients with acute coronary syndrome or myocardial infarction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}